# Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects

> **NCT00858754** · PHASE4 · WITHDRAWN · sponsor: **Bausch Health Americas, Inc.**

## Conditions studied

- Opioid-Induced Constipation

## Interventions

- **DRUG:** methylnaltrexone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00858754
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-03
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn \[This study was terminated early by Wyeth, prior to dosing any subjects, for business reasons not related to safety.
- **Last updated:** 2019-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858754, "Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00858754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*